Medical Research & Pharma
Pharmacovigilance Reporter
Safety reporting that never misses a signal
7
VAL
5
FIT
5
EASE
6
ODOO
7
GC
5
RISK
6.3
Score
Why This Workflow Matters
The business case for implementing this workflow.
Pharmacovigilance is legally mandated for all marketed drugs and investigational products. Late or incomplete safety reports result in FDA warning letters, fines, and potential criminal liability. Small pharma companies spend $500K-$2M annually on PV operations. Case processing backlogs are common, and signal detection from accumulated data requires specialized statistical expertise most companies lack.
The Bigger Puzzle
How AI + Odoo creates something greater than the sum of its parts.
AI + Odoo Synergy
Adverse event reported → ICSR created in Quality module → AI generates MedDRA-coded narrative → case assessed for severity and causality → serious cases reported to regulators within required timelines via Documents → accumulated cases analyzed for signals → PSUR/PBRER generated periodically → safety signals flagged to clinical team via Discuss → label updates recommended when signals confirmed → all activities tracked in Project with regulatory deadlines.
Odoo Apps Activated
Quality
Documents
Project
Discuss
Knowledge
Current Alternatives & Why They Fall Short
The existing solutions and their limitations.
Oracle Argus Safety
Industry-leading pharmacovigilance case management system used by major pharmaceutical companies worldwide.
$200,000-$1,000,000+/year — Enterprise licensing plus implementation
Limitations
- Extremely expensive — prohibitive for small pharma and biotech
- Complex implementation requiring 6-12 months
- No AI-powered narrative generation
- Requires dedicated PV system administrators
Why RebusAI is Better
AI-powered case processing and narrative generation within Odoo's Quality framework, at a fraction of Oracle Argus cost. Makes pharmacovigilance accessible to small pharma without million-dollar system investments.
PV Outsourcing (IQVIA, Covance)
Contract research organizations offering pharmacovigilance services including case processing, signal detection, and regulatory reporting.
$100-$500 per case + $50,000-$200,000/year for signal detection and PSUR services
Limitations
- Per-case costs add up quickly as product matures
- Loss of institutional PV knowledge to external vendor
- Response time depends on vendor workload
- Switching vendors is extremely disruptive
Why RebusAI is Better
Build internal PV capability with AI assistance rather than outsourcing institutional knowledge. AI handles routine case processing while your team focuses on medical assessment and signal evaluation.
Manual Processing (Excel + Word)
Small companies processing adverse events manually: Excel tracking spreadsheets, Word narrative templates, and email-based reporting.
Low technology cost — But high compliance risk and labor cost
Limitations
- Regulatory timeline tracking is manual and error-prone
- No signal detection capability
- Audit trail insufficient for regulatory inspections
- Scales terribly as case volume grows
- One missed deadline can trigger FDA enforcement action
Why RebusAI is Better
Automated timeline tracking, AI-generated narratives, signal detection from accumulated data, and complete audit trails — replacing manual processes that put your company at regulatory risk.
Implementation Approach
How to bring this workflow to life.
Complex regulatory workflow requiring MedDRA integration and regulatory timeline management. 6-8 week implementation due to compliance criticality and validation requirements.
Ready to Build This Workflow?
Turn Pharmacovigilance Reporter into a competitive advantage with RebusAI + Odoo.
Get Started Free
Explore Other Industries